CNS Gene Therapy
21 – 30 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
FACS binding assay for analysing GDNF interactions.
(
- Contribution to journal › Article
- 2012
-
Mark
Destabilizing domains mediate reversible transgene expression in the brain.
(
- Contribution to journal › Article
-
Mark
Novel disease-specific promoters for use in gene therapy for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
(
- Contribution to journal › Article
-
Mark
Difficult Questions and Ambivalent Answers on Genetic Testing
(
- Contribution to journal › Article
- 2011
-
Mark
Activity-dependent long-term plasticity of afferent synapses on grafted stem/progenitor cell-derived neurons.
(
- Contribution to journal › Article
-
Mark
Knock down of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.
(
- Contribution to journal › Article
- 2010
-
Mark
A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System
(
- Contribution to journal › Article
- 2009
-
Mark
Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants
(
- Contribution to journal › Article